2018
DOI: 10.1016/j.fitote.2018.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of aldose reductase activity by chemotypes extracts with high content of cannabidiol or cannabigerol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
38
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 41 publications
(41 citation statements)
references
References 36 publications
3
38
0
Order By: Relevance
“…The therapeutic potential of CBD has been evaluated in cardiovascular, neurodegenerative, cancer, and metabolic diseases, which are usually accompanied by oxidative stress and inflammation [6]. One of the best studied uses of CBD is for therapeutic effect in diabetes and its complications in animal and human studies [7]. CBD, by activating the cannabinoid receptor, CB2, has been shown to induce vasodilatation in type 2 diabetic rats [8,9], and by activating 5-HT 1A receptors, CBD showed a therapeutic effect in diabetic neuropathy [10].…”
Section: Introductionmentioning
confidence: 99%
“…The therapeutic potential of CBD has been evaluated in cardiovascular, neurodegenerative, cancer, and metabolic diseases, which are usually accompanied by oxidative stress and inflammation [6]. One of the best studied uses of CBD is for therapeutic effect in diabetes and its complications in animal and human studies [7]. CBD, by activating the cannabinoid receptor, CB2, has been shown to induce vasodilatation in type 2 diabetic rats [8,9], and by activating 5-HT 1A receptors, CBD showed a therapeutic effect in diabetic neuropathy [10].…”
Section: Introductionmentioning
confidence: 99%
“…However, a number of other compounds such as alkanes and some phytocannabinoids, like those having propyl side chains, common only in a specific cannabis biotype (Hendriks, Malingré, Batterman, & Bos, ; Hillig & Mahlberg, ; Ross & ElSohly, ), were found. Recently, a growing interest has been focused on C. sativa biotypes with low content of Δ 9 ‐tetrahydrocannabinol (Δ 9 ‐THC <0.2%) and with a high titre of non‐psichotropic cannabinoids such as cannabidiol (CBD)/cannabidiolic acid (CBDA) or cannabigerol (CBG)/cannabigerolic acid (CBGA) (Smeriglio et al, ). This, for a possible use in therapy of Cannabis ‐based medicinal extracts free of the Δ 9 ‐THC psychotropic side effects (Iuvone et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…Chromatographic separation of the EtOAc extracts from the aerial parts of C. sativa yielded ve new compounds (1-5) and twelve known compounds (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17), named D 9 -trans-tetrahydrocannabivarin (6), 22 cannabinol (7), 23 cannabispirone (8), 24 erythrodiol (9), 25 oleanolic acid (10), 26 maslinic acid (11), 27 phydroxybenzaldehyde (12), 28 (E)-methyl p-hydroxycinnamate (13), 29 (Z)-methyl p-hydroxycinnamate (14), 30 ferulic acid (15), 31 phylligenol (16), 32 and skullcapavone II (17) 33 (Fig. 1).…”
Section: Resultsmentioning
confidence: 99%
“…In summary, three new cannabinoids, cannabisativas A-C (1-3), two new phenolic acids, (7Z,9Z)-cannabiphenolic acid A (4) and (8S,9Z)-cannabiphenolic acid B (5), along with twelve known compounds (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17), were identied from the aerial parts of Cannabis sativa L. subsp. sativa.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation